Regeneron Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited: Annual Revenue Growth Compared

Pharma Giants' Revenue Race: 2014-2023

__timestampDr. Reddy's Laboratories LimitedRegeneron Pharmaceuticals, Inc.
Wednesday, January 1, 20141321700000002819557000
Thursday, January 1, 20151481890000004103728000
Friday, January 1, 20161547080000004860427000
Sunday, January 1, 20171408090000005872227000
Monday, January 1, 20181420280000006710800000
Tuesday, January 1, 20191538510000007863400000
Wednesday, January 1, 20201746000000008497100000
Friday, January 1, 202118972200000016071700000
Saturday, January 1, 202221439100000012172900000
Sunday, January 1, 202324587900000013117200000
Monday, January 1, 202427916400000014202000000
Loading chart...

In pursuit of knowledge

A Tale of Two Pharmaceuticals: Revenue Growth from 2014 to 2023

In the competitive world of pharmaceuticals, revenue growth is a key indicator of success. This chart compares the annual revenue growth of Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023. Over this period, Dr. Reddy's Laboratories has shown a consistent upward trend, with revenue increasing by approximately 111% from 2014 to 2023. In contrast, Regeneron Pharmaceuticals experienced a more volatile growth pattern, with a notable peak in 2021, where revenue surged by nearly 90% compared to 2014. However, data for 2024 is missing, leaving a gap in Regeneron's recent performance. This comparison highlights the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions can significantly impact financial outcomes. As we look to the future, these companies' ability to innovate and adapt will be crucial in maintaining their growth trajectories.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025